Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review.
Rafael Leite PachecoAna Luiza Cabrera MartimbiancoFelipe RoitbergGerald W PragerRachel RieraPublished in: JCO global oncology (2021)
The findings emphasize the infrequency of measuring and reporting mitigation strategies that specifically address patients' outcomes and thus a scarcity of high-quality evidence to inform program development. This review reinforces the need of adopting standardized measurement methods to monitor the impact of the mitigation strategies proposed to reduce the effects of delays and disruptions in cancer health care because of COVID-19.
Keyphrases
- systematic review
- coronavirus disease
- sars cov
- healthcare
- end stage renal disease
- climate change
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- papillary thyroid
- peritoneal dialysis
- squamous cell carcinoma
- randomized controlled trial
- adipose tissue
- young adults
- metabolic syndrome
- lymph node metastasis